Your browser doesn't support javascript.
loading
Incidence, Severity, and Presentation of Type 2 Diabetes in Youth During the First and Second Year of the COVID-19 Pandemic.
Sasidharan Pillai, Sabitha; Has, Phinnara; Quintos, Jose Bernardo; Serrano Gonzalez, Monica; Kasper, Vania L; Topor, Lisa Swartz; Fredette, Meghan E.
Afiliación
  • Sasidharan Pillai S; 1Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, Hasbro Children's Hospital, Providence, RI.
  • Has P; 2The Warren Alpert Medical School of Brown University, Providence, RI.
  • Quintos JB; 3Lifespan Biostatistics, Epidemiology and Research Design, Rhode Island Hospital, Providence, RI.
  • Serrano Gonzalez M; 1Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, Hasbro Children's Hospital, Providence, RI.
  • Kasper VL; 2The Warren Alpert Medical School of Brown University, Providence, RI.
  • Topor LS; 1Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, Hasbro Children's Hospital, Providence, RI.
  • Fredette ME; 2The Warren Alpert Medical School of Brown University, Providence, RI.
Diabetes Care ; 46(5): 953-958, 2023 05 01.
Article en En | MEDLINE | ID: mdl-36637859
ABSTRACT

OBJECTIVE:

To describe the evolving impact of the coronavirus disease 2019 pandemic on the incidence and presentation of new-onset pediatric type 2 diabetes. RESEARCH DESIGN AND

METHODS:

Retrospective medical record review of youth with new-onset type 2 diabetes comparing the prepandemic period (1 January 2017-29 February 2020) with the first (1 March 2020-31 December 2020) and second pandemic year (1 January 2021-31 December 2021).

RESULTS:

The annualized incidence of type 2 diabetes increased nearly threefold during the pandemic versus prior, with a 61% increase in the 2nd versus 1st year. BMI increased during the pandemic versus prior (129% of 95th percentile vs. 141%, P = 0.02). In the 1st year, patients were younger (12.9 years vs. 14.8, P < 0.001), with higher incidence of diabetic ketoacidosis and/or hyperglycemic hyperosmolar syndrome (20% vs. 3.5%, P = 0.02) versus prior.

CONCLUSIONS:

Providers should be aware of the escalating incidence of youth-onset type 2 diabetes to avoid delays in diagnosis and inform educational programs to combat the continued impact of the pandemic on health outcomes.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_pneumonia Asunto principal: Cetoacidosis Diabética / Diabetes Mellitus Tipo 2 / COVID-19 Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Humans Idioma: En Revista: Diabetes Care Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_pneumonia Asunto principal: Cetoacidosis Diabética / Diabetes Mellitus Tipo 2 / COVID-19 Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Humans Idioma: En Revista: Diabetes Care Año: 2023 Tipo del documento: Article
...